OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH
Saved in:
Published in | Digestive and liver disease Vol. 51; p. e101 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
25.03.2019
|
Online Access | Get full text |
Cover
Loading…
Author | Buda, A. Barberio, B. Zingone, F. Lorenzon, G. Savarino, E. Facchin, S. D'Incà, R. |
---|---|
Author_xml | – sequence: 1 givenname: A. surname: Buda fullname: Buda, A. – sequence: 2 givenname: S. surname: Facchin fullname: Facchin, S. – sequence: 3 givenname: G. surname: Lorenzon fullname: Lorenzon, G. – sequence: 4 givenname: B. surname: Barberio fullname: Barberio, B. – sequence: 5 givenname: F. surname: Zingone fullname: Zingone, F. – sequence: 6 givenname: E. surname: Savarino fullname: Savarino, E. – sequence: 7 givenname: R. surname: D'Incà fullname: D'Incà, R. |
BookMark | eNqFkdGKnDAYhaVsobvbPkIhlzMXzibRRO1NyWjGCUQjJrLtVZh1IljamUVLoc_dF9jotte9Ssh_zvcfcu6Cm8v14oLgI4I7BBF90IhkMEwpSTco20YQpSTM3gS3KE3SMCIU3_j7P8m74G6ev0GIESXwNvij8h3MdhEQ9UGKL6Jie1AozcOWF11uhKr9ZB2yqmJGtV_BXj1yCQqhOdMcbMS-2IKGGcFroxdx0yqp6pIXoOC8AS2vhNYe9Ak0yniRYBKIqpEiZwtfA7-j4CHXOZPrC9CmZYaXgq885hHeIsWBg1yK2vsk0NwYUZfgUZij6owXmSNvWcM7I3JQtF0JKlULH3hRbUxRbQFrfDSWH98Hb4fT99l9-HveB92Bm_wYSlUu8LBHEGchdiihFMNswMNpeKKJi3ucDgjH5xNMSNbjhFAaDZAQHMcI-x-OCB5cGj3FNIqT6D4gr9x-us7z5Ab7PI0_TtNvi6BdmrNrc3apxaLMrs3ZzPs-v_qcD_drdJOd-9FdenceJ9f_tOfr-B_CC_e5jn8 |
ContentType | Journal Article |
Copyright | 2019 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. |
Copyright_xml | – notice: 2019 Editrice Gastroenterologica Italiana S.r.l. All rights reserved. |
DBID | AAYXX CITATION |
DOI | 10.1016/S1590-8658(19)30185-9 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1878-3562 |
EndPage | e101 |
ExternalDocumentID | 10_1016_S1590_8658_19_30185_9 S1590865819301859 |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABBQC ABJNI ABLVK ABMAC ABMZM ABYKQ ACDAQ ACGFS ACRLP ADBBV ADEZE AEBSH AEKER AENEX AEVXI AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FD8 FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF IHE J1W KOM LCYCR M41 MO0 N9A O-L O9- OAUVE OC. ON0 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SPCBC SSH SSZ T5K Z5R ~G- AAQXK AAXKI AAYXX ABFNM ABXDB ADMUD AFJKZ AKRWK ASPBG AVWKF AZFZN CITATION FGOYB HZ~ R2- SEW |
ID | FETCH-LOGICAL-c1029-2e1766209f2fafb67e4c28f124da0759c275663f05524412590352fe83b463473 |
IEDL.DBID | AIKHN |
ISSN | 1590-8658 |
IngestDate | Thu Sep 26 18:41:45 EDT 2024 Fri Feb 23 02:26:58 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1029-2e1766209f2fafb67e4c28f124da0759c275663f05524412590352fe83b463473 |
ParticipantIDs | crossref_primary_10_1016_S1590_8658_19_30185_9 elsevier_sciencedirect_doi_10_1016_S1590_8658_19_30185_9 |
PublicationCentury | 2000 |
PublicationDate | 2019-03-25 |
PublicationDateYYYYMMDD | 2019-03-25 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-25 day: 25 |
PublicationDecade | 2010 |
PublicationTitle | Digestive and liver disease |
PublicationYear | 2019 |
Publisher | Elsevier Ltd |
Publisher_xml | – name: Elsevier Ltd |
SSID | ssj0021650 |
Score | 2.2724106 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | e101 |
Title | OC.09.3 INFLIXIMAB DOSE-REDUCTION IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS IN PROLONGED DEEP REMISSION: POTENTIAL IMPLICATIONS ON DE-ESCALATION STRATEGIES IN A REAL LIFE CLINICAL SETTING WITHOUT A THERAPEUTIC DRUG MONITORING (TDM) APPROACH |
URI | https://dx.doi.org/10.1016/S1590-8658(19)30185-9 |
Volume | 51 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELZ2uxLigmAXxPJYzQGh9pBt3q25uYnbGPJS4mjLKUrTRNoDZYWWAxf-NH-AsZsWkBAHrvbMxMqMZj7b4xlC3rToFhGYowYcrzVcukE_6Nszo6Wu77R915i6nU-S-lHlvl976xMSHN7CqLTKwffvfbr21sPIdPib07vb22lpqXbdGEARgpgYdegpOcNw5LojcsbEhyg97rssXzdqVfSGYvj1kGcvRA-OLTrRcgz69xD1W9hZPiaPBrwIbL-kJ-Sk252TC7bDvfKnb_AWdAanPho_Jw-S4aL8gvzIAlVY1QGRLmOxFglbQJiV3ChUqx11LIUzepIlCZNZ8REW2Q2PIRQlZyWHsViEE8iZFDyVpSLOiyzO0hUPIeQ8hwIVqD3xO8gziUSCxSCS_Pg0GfAbITd4GbBYj4Dqzyz5CgGoksdQBLLEYskhiEWqCjNAyaUU6QpuhIyySiKRjHjBcl5JEUBYVCvAICBwwYpqLMNkAizHpbEgekqqJZdBZAz9HYzWUlk3dqeqU9om7e2-6Tf-rHNbe94j4tg2iGRoq0rT-05veh6CEERiVBVv7bu5s0FDcmfOMzLafd51zwlQd-uhr5q3zgYBoCqT3zqN17sOytya8-aSXB9UWt_ty3jUx_w2ZQO1soHaorW2gZpekvlB8fUf9lhjqPk364v_Z31JHiIgoyrHzfZekdH9l6_dawQ995srcnr93boaTPsnB0vmCQ |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuCHZBLM85INQesm3zas3NTdzGkJcSV9s9RW2aSHugu1otBy78af4AM25aQEIcuNrjieUZzXxJxt8w9r7GsIjAHC3geLXl8jXGQd8eWzV3fadum9XQtPNJUj9auJ-W3vKIBfu7MFRW2cX-XUw30bobGXSnObi5uhqUI2rXjQkUIcgQsw6_x-4TGqC6rvPvhzoPe-SbNq0kbZH4r2s8OxVmsDfifaPF4n9PUL8lndkT9rhDiyB2G3rKjprtCTsVW3xT_vINPoCp3zQfxk_Yg6T7TX7KfmQB0ao6oNJZrJYqEVMIs1JaBTXaoY9SOGMmRZIInRWXMM0uZAyhKqUoJfTUNOxDLrSSqS5JOC-yOEvnMoRQyhwKNJ-Jwx8hzzQKKRGDSvLDxWTAZ4TSkmUgYjMC1J1ZyznCT9InUAUuidVMQhCrlGgZoJRaq3QOF0pH2UKjkI5kIXK50CqAsFjMAVOAwg2TVE-HSR9EjlsTQfSMLWZSB5HVdXew6hHV3NgNcVPaQ97a7apd--PGre1Ji3hjs0Icw2sipvedduh5CEEQh3Gibm2bibNGN3LHznN2vL3eNi8YcHfjYaSa1M4a4R-R5NfOymtdB3VuhpPVGTvfm7S62ZF4VIfqNvKBinygGvHK-EDFz9hkb_jqD2-sMNH8e-nL_1_6jj2MdBJXeOifX7FHCM04VbvZ3mt2fHf7tXmD8Odu_da490_nvebe |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=OC.09.3+INFLIXIMAB+DOSE-REDUCTION+IN+INFLAMMATORY+BOWEL+DISEASE+%28IBD%29+PATIENTS+IN+PROLONGED+DEEP+REMISSION%3A+POTENTIAL+IMPLICATIONS+ON+DE-ESCALATION+STRATEGIES+IN+A+REAL+LIFE+CLINICAL+SETTING+WITHOUT+A+THERAPEUTIC+DRUG+MONITORING+%28TDM%29+APPROACH&rft.jtitle=Digestive+and+liver+disease&rft.au=Buda%2C+A.&rft.au=Facchin%2C+S.&rft.au=Lorenzon%2C+G.&rft.au=Barberio%2C+B.&rft.date=2019-03-25&rft.pub=Elsevier+Ltd&rft.issn=1590-8658&rft.eissn=1878-3562&rft.volume=51&rft.spage=e101&rft.epage=e101&rft_id=info:doi/10.1016%2FS1590-8658%2819%2930185-9&rft.externalDocID=S1590865819301859 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1590-8658&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1590-8658&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1590-8658&client=summon |